Corporació Sanitaria Parc Taulí

Sabadell 08208

0 studies enrolling now · 2 studies all time

What they study most

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer, Prostate Cancer Metastatic

Studies at this site

• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression — Completed
• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed